Homozygous deletion of the human insulin receptor gene results in leprechaunism. 1993

E Wertheimer, and S P Lu, and P F Backeljauw, and M L Davenport, and S I Taylor
Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland 20892.

Homozygous inactivation of a gene, as is frequently performed to generate mouse models, provides an opportunity to elucidate the role that the gene plays in normal physiology. However, studies of human disease provide direct insight into the effect of inactivating mutations in man. In this investigation, we have identified a one year-old boy from a consanguineous pedigree who is homozygous for deletion of the insulin receptor gene resulting in leprechaunism. Contrary to previous predictions, the complete deletion of the insulin receptor gene is compatible with life.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002658 Developmental Disabilities Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed) Child Development Deviations,Child Development Disorders,Child Development Disorders, Specific,Developmental Delay Disorders,Disabilities, Developmental,Development Disorders, Child,Child Development Deviation,Child Development Disorder,Development Deviation, Child,Development Deviations, Child,Development Disorder, Child,Developmental Delay Disorder,Developmental Disability,Deviation, Child Development,Disability, Developmental
D003241 Consanguinity The magnitude of INBREEDING in humans. Inbreeding, Human,Consanguineous Marriage,Consanguinous Mating,Consanguineous Marriages,Consanguinities,Consanguinous Matings,Human Inbreeding,Human Inbreedings,Inbreedings, Human,Marriage, Consanguineous,Marriages, Consanguineous,Mating, Consanguinous,Matings, Consanguinous
D004392 Dwarfism A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height. Nanism
D005145 Face The anterior portion of the head that includes the skin, muscles, and structures of the forehead, eyes, nose, mouth, cheeks, and jaw. Faces
D005260 Female Females

Related Publications

E Wertheimer, and S P Lu, and P F Backeljauw, and M L Davenport, and S I Taylor
October 1993, Lancet (London, England),
E Wertheimer, and S P Lu, and P F Backeljauw, and M L Davenport, and S I Taylor
July 1993, Lancet (London, England),
E Wertheimer, and S P Lu, and P F Backeljauw, and M L Davenport, and S I Taylor
April 1997, Diabetologia,
E Wertheimer, and S P Lu, and P F Backeljauw, and M L Davenport, and S I Taylor
February 2002, Nihon rinsho. Japanese journal of clinical medicine,
E Wertheimer, and S P Lu, and P F Backeljauw, and M L Davenport, and S I Taylor
November 1995, Prenatal diagnosis,
E Wertheimer, and S P Lu, and P F Backeljauw, and M L Davenport, and S I Taylor
July 1995, Prenatal diagnosis,
E Wertheimer, and S P Lu, and P F Backeljauw, and M L Davenport, and S I Taylor
July 2009, Journal of pediatric endocrinology & metabolism : JPEM,
E Wertheimer, and S P Lu, and P F Backeljauw, and M L Davenport, and S I Taylor
December 1989, The American journal of the medical sciences,
E Wertheimer, and S P Lu, and P F Backeljauw, and M L Davenport, and S I Taylor
July 1997, Prenatal diagnosis,
Copied contents to your clipboard!